Rottman; James

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rottman; James.The latest application filed is for "aptamer therapeutics useful in the treatment of complement-related disorders".

Company Profile

0.9.10

Rottman; James - Sudbury MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Aptamer Therapeutics Useful In The Treatment Of Complement-related Disorders App 20210332361 - Benedict; Claude ; et al.	2021-10-28
Aptamer therapeutics useful in the treatment of complement-related disorders Grant 10,947,544 - Benedict , et al. March 16, 2	2021-03-16
Aptamer Therapeutics Useful In The Treatment Of Complement-related Disorders App 20190185858 - BENEDICT; CLAUDE ; et al.	2019-06-20
Aptamer Therapeutics Useful In The Treatment Of Complement-related Disorders App 20180030446 - BENEDICT; Claude ; et al.	2018-02-01
Aptamer therapeutics useful in the treatment of complement-related disorders Grant 9,617,546 - Benedict , et al. April 11, 2	2017-04-11
Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders App 20150159158 - Benedict; Claude ; et al.	2015-06-11
Aptamer therapeutics useful in the treatment of complement-related disorders Grant 8,946,184 - Benedict , et al. February 3, 2	2015-02-03
Aptamer Therapeutics Useful In The Treatment Of Complement-related Disorders App 20130237589 - BENEDICT; Claude ; et al.	2013-09-12
Aptamer therapeutics useful in the treatment of complement-related disorders Grant 8,436,164 - Benedict , et al. May 7, 2	2013-05-07
Aptamer Therapeutics Useful In The Treatment Of Complement-related Disorders App 20120322860 - BENEDICT; CLAUDE ; et al.	2012-12-20
Aptamer therapeutics useful in the treatment of complement-related disorders Grant 8,236,773 - Benedict , et al. August 7, 2	2012-08-07
Ferroportin Antibodies And Methods Of Use App 20110274691 - Arvedson; Tara ; et al.	2011-11-10
Aptamer therapeutics useful in the treatment of complement-related disorders Grant 7,803,931 - Benedict , et al. September 28, 2	2010-09-28
Aptamer therapeutics useful in the treatment of complement-related disorders Grant 7,579,456 - Benedict , et al. August 25, 2	2009-08-25
Aptamer therapeutics useful in the treatment of complement-related disorders Grant 7,538,211 - Benedict , et al. May 26, 2	2009-05-26
Aptamer therapeutics useful in the treatment of complement-related disorders App 20070048248 - Benedict; Claude ; et al.	2007-03-01
Aptamer therapeutics useful in the treatment of complement-related disorders App 20060105980 - Benedict; Claude ; et al.	2006-05-18
Aptamer therapeutics useful in the treatment of complement-related disorders App 20060018871 - Benedict; Claude ; et al.	2006-01-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.